Pharmacological actions and potential uses of Momordica charantia: a review.
about
Novel nutraceutic therapies for the treatment of metabolic syndromeTraditional Indian medicines used for the management of diabetes mellitusThe use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective?Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeBitter melon: a panacea for inflammation and cancerModel Analytical Development for Physical, Chemical, and Biological Characterization of Momordica charantia Vegetable DrugStructure modeling and antidiabetic activity of a seed protein of Momordica charantia in non-obese diabetic (NOD) miceDe Novo Assembly of Bitter Gourd Transcriptomes: Gene Expression and Sequence Variations in Gynoecious and Monoecious Lines.Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.MS-1020 is a novel small molecule that selectively inhibits JAK3 activity.The therapeutic potential of medicinal foods.Comparative Study of Hydroalcoholic Extracts of Momordica charantia L. against Foodborne PathogensEffect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro.An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways.Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: a Tanzania medicinal plantSynthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases.Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia.Kuguaglycoside C, a constituent of Momordica charantia, induces caspase-independent cell death of neuroblastoma cells.Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley ratsCardio-protective and anti-cancer therapeutic potential of Nigella sativa.AMPK as Target for Intervention in Childhood and Adolescent ObesityUse of laser-induced breakdown spectroscopy for the detection of glycemic elements in Indian medicinal plants.Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approachComparison of plants used for skin and stomach problems in Trinidad and Tobago with Asian ethnomedicine.A pharmacological appraisal of medicinal plants with antidiabetic potentialInhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantiaWild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial.Ethnomedical research and review of Q'eqchi Maya women's reproductive health in the Lake Izabal region of Guatemala: Past, present and future prospects.Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats.The effects of Momordica charantia on obesity and lipid profiles of mice fed a high-fat diet.Effect of superfine grinding on antidiabetic activity of bitter melon powder.Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter GourdPlant-derived therapeutics for the treatment of metabolic syndrome.Effect of active fraction isolated from the leaf extract of Dregea volubilis [Linn.] Benth. on plasma glucose concentration and lipid profile in streptozotocin-induced diabetic rats.The effects of chloroform, ethyl acetate and methanolic extracts of Brassica rapa L. on cell-mediated immune response in miceThe Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress.Effects of Momordica charantia L. on the blood rheological properties in diabetic patients.
P2860
Q26748558-CF1469FF-0E70-49CC-9841-AB67D7A1A429Q26829674-AA063ECB-3DCB-4AAF-AD8F-B40CF0F30153Q27011434-D10C60C5-771E-4781-90CF-BA465593DA38Q28081950-E4CCAD9B-A05D-4BA7-9F44-5FD3A013E10CQ28817944-DDD0DDEC-2488-4D8F-ACD3-AFB104242261Q28829514-CD15D2D9-2EEA-407B-9B6B-6C72715CF872Q30353501-A739DC29-63C6-4BEE-B0DA-7FA419B53360Q30388609-AFAF3DC8-7738-4F03-A3E3-1046EA4CBAEEQ33433522-E4B4C9D4-E112-40E7-BF4D-D43999615D7BQ33507716-56CE8622-63D4-446B-9789-BBB0216FDC03Q33562817-32780B0C-E249-4287-AED1-EFDE79DDD88BQ33621115-E8EA07A4-B5F2-4081-81D1-9A501ACF6D5CQ33684917-4FD3A6FC-F26D-4DA7-8A11-6BC733A44296Q33877627-899621B3-1EB1-4A4F-87C0-6B2140F05749Q34034102-969A77D3-8F7A-448A-9552-7A3BFFCF3DF9Q34045439-0AA3975B-3C0D-420F-B18C-FEF17E89674DQ34100101-AD945CA4-2941-42EA-9986-229F6AE3855EQ34162283-57910E82-71B9-42A2-813F-5D4510EE8CEBQ34188462-5242AFCB-D1DE-4014-943E-3D69BA5ABCEFQ34408500-BD0B046F-F2E0-4668-B327-B983D40AD8C1Q34421588-01BC577D-0763-407E-8351-CA57984864C9Q34471036-94FA7598-9824-4955-9D70-2A3A23DB7DA5Q34557477-A3BF1C98-F3C0-4C24-BA4C-C03FD0E8C06FQ35042327-6CB0C51D-BE31-4D6E-8935-5F38C1EC4470Q35073237-043F7240-E59F-43D3-AC29-047BBB13A761Q35206870-4C1377D0-4426-4F85-BDD9-4925E06E2B3CQ35610031-120C9E6A-AAFF-417C-B452-519BC889D9D5Q35770444-EDE08DA6-DD5A-4A7A-A6B7-646D345A5D99Q35841795-6B444E33-EC9D-4F84-A489-068345C5AB9AQ35848632-6F1D25C5-CBF8-402A-BA2C-0005CEB5C1E6Q35872446-009F7E5A-522C-4B34-A83D-C84BC3B66F09Q36063406-06281B8C-31DD-4926-AFC1-08FA0D647E84Q36075560-E203BC3C-730B-473B-8F4D-4E8049234FA5Q36432442-8684059E-8BB4-4EF0-A3BB-D6484DBA5047Q36752298-AFF42D61-BE6D-4ED5-B022-ED599CD8A1ACQ37128203-745D7352-8DFA-4C9E-BDE5-A82761607F19Q37131987-5E8235D9-C78F-4758-B931-341453DA3C7AQ37150833-CCCAB17A-0F6D-4EA8-9C99-5C2516DEC090Q37401512-D13FF57F-E76E-40F7-B4E6-C258D7B4FEF0Q37594951-6BA576E8-C6D3-4CCE-A8D6-C733C32F5259
P2860
Pharmacological actions and potential uses of Momordica charantia: a review.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacological actions and potential uses of Momordica charantia: a review.
@ast
Pharmacological actions and potential uses of Momordica charantia: a review.
@en
Pharmacological actions and potential uses of Momordica charantia: a review.
@nl
type
label
Pharmacological actions and potential uses of Momordica charantia: a review.
@ast
Pharmacological actions and potential uses of Momordica charantia: a review.
@en
Pharmacological actions and potential uses of Momordica charantia: a review.
@nl
prefLabel
Pharmacological actions and potential uses of Momordica charantia: a review.
@ast
Pharmacological actions and potential uses of Momordica charantia: a review.
@en
Pharmacological actions and potential uses of Momordica charantia: a review.
@nl
P1476
Pharmacological actions and potential uses of Momordica charantia: a review.
@en
P2093
P304
P356
10.1016/J.JEP.2004.03.035
P577
2004-07-01T00:00:00Z